NATPARA^® is a parathyroid hormone indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism. Because of the potential risk of osteosarcoma, NATPARA is recommended only for patients who cannot be well-controlled on calcium supplements and active forms of vitamin D alone. NATPARA was not studied in patients with hypoparathyroidism caused by calcium-sensing receptor mutations. NATPARA was not studied in patients with acute post-surgical hypoparathyroidism.

See full indication

See less indication

See full indication

See less indication

Find out how NATPARA was able to affect serum calcium levels as an adjunct to calcium and vitamin D in patients with hypoparathyroidism¹

View Clinical Results

NATPARA is a once-daily, self-administered injectable parathyroid hormone¹

See How It Works

Could one of your patients be appropriate for NATPARA?

Learn More

Ready to prescribe
NATPARA?

Get Started

Attend a Speaker Event

Join your colleagues for an educational program about hypoparathyroidism and NATPARA

{{event.VenueName}}
{{event.VenueAddress}}
{{event.VenueCity}}, {{event.VenueState}} {{event.VenueZip}}

{{event.StartTime}} - {{event.EndTime}} {{event.TimeZone}}

Reference: 1. NATPARA [package insert]. Shire-NPS Pharmaceuticals, Inc.

For patients with hypoparathyroidism

What is the right
calcium balance?

NATPARA is a once-daily, self-administered injectable parathyroid hormone¹

Could one of your patients be appropriate for NATPARA?

Ready to prescribe
NATPARA?

Attend a Speaker Event

NATPARA is a once-daily, self-administered injectable parathyroid hormone1

Could one of your patients be appropriate for NATPARA?

Ready to prescribe NATPARA?

Attend a Speaker Event

NATPARA is a once-daily, self-administered injectable parathyroid hormone¹

Ready to prescribe
NATPARA?